FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10422911000001106: Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35728701000001113 Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52386801000001119 Aclasta 5mg/100ml infusion bottles (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Zoledronic acid 5mg/100ml infusion bottles true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Zoledronic acid 5mg/100ml infusion bottles false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Zoledronic acid 5mg/100ml solution for injection bottles false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has active ingredient Zoledronic acid true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has active ingredient Zoledronic acid monohydrate false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Solution for injection false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Zoledronic acid 5mg injection solution 100mL bottle false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Aclasta true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Zoledronic acid true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Zoledronic acid monohydrate false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance Zoledronic acid true Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Zoledronic acid hydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Is pack of False Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) 1 bottle Has AMP True Aclasta 5mg/100ml solution for infusion bottles (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start